Larapam (Tramadol Hydrochloride)

Tramadol works by weakly activating mu‑opioid receptors and by blocking the reuptake of norepinephrine and serotonin, which together enhance the body’s natural pain‑inhibiting pathways and reduce the perception of pain.

The appropriate dose of Larapam is determined by the prescribing clinician based on the patient’s pain severity, medical history, and response to therapy. Dosage adjustments may be needed for renal or hepatic impairment.

Safety of tramadol during pregnancy or lactation has not been fully established. Clinicians should weigh potential benefits against risks and consider alternative therapies when treating pregnant or nursing patients.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with stronger opioids such as morphine, tramadol offers a lower risk of respiratory depression but still provides effective analgesia for moderate pain. Its dual mechanism also differentiates it from pure mu‑opioid agonists, potentially offering benefits in certain pain syndromes.

Larapam should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Larapam is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food may reduce gastrointestinal upset. Swallow tablets whole; do not crush or chew unless specifically instructed.

Serious risks include respiratory depression, seizures, serotonin syndrome when combined with serotonergic drugs, severe allergic reactions, and the potential for dependence or addiction. Patients should be monitored closely for these events, especially during dose escalation.

Larapam is contraindicated in patients with known hypersensitivity to tramadol or any component of the formulation, those taking monoamine oxidase inhibitors, and individuals with uncontrolled severe respiratory depression. Caution is also advised for patients with a history of seizures or substance abuse.